Subscribe to magazine
Subscribe to newsletters
Computed Tomography (CT)
Magnetic Resonance Imaging (MRI)
Radiation Dose management
Intravascular imaging systems
Peripheral Artery Disease
Leads, implantable devices
Implantable cardioverter defibrillators (ICD)
Cardiac resynchronization therapy devices (CRT)
Heart Valve Technology
Left atrial appendage (LAA) occluders
Structural heart occluders/closure devices
Clinical decision support
201 London Parkway
Birmingham, AL 35211
April 17, 2014
New Data Show Benefit of Comprehensive Lipid Testing to Determine Risk for Coronary Events
Data presented from two meta-analyses using the Atherotech Vertical Auto Profile (VAP) lipid panel showed the impact...
March 27, 2014
Atherotech Opens Patient Service Center in Sarasota, Fla.
Atherotech Diagnostics Lab opened its patient service center in Sarasota, Fla.
September 13, 2013
Atherotech Diagnostics Lab Adds Genetic Testing to Optimize Cardiovascular Disease Treatment and Outcomes
Atherotech Diagnostics Lab has added three new genetic tests to its cardiometabolic test offering: warfarin sensitivity...
April 04, 2013
Atherotech Diagnostics Lab Adds Corgenix AspirinWorks Test for Aspirin Effect
Corgenix Medical Corp. has announced that Atherotech Diagnostics Lab will carry its AspirinWorks Test for determining...
January 30, 2012
VAP Test Improves ID of Carotid Intima-Media Thickness Progression
January 30, 2012 — Expanded cholesterol assessment of moderate risk patients can play an important role in identifying...
June 29, 2011
Partnership Brings Together Diabetes, Cardiovascular Testing
June 29, 2011 – An industry-first collaboration is bringing together cardiovascular testing company Atherotech...
March 11, 2009
Atherotech Adds Heart Disease, Diabetes Risk Marker to Cholesterol Test
March 11, 2009 - The VAP Cholesterol Test from Atherotech Inc. is now available with apolipoprotein A (apoAI),...
Scranton Gillette Communications
. All Rights Reserved.